13F-HR filed by NOVO HOLDINGS A/S
NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-16, with 17 holding rows worth $912,484,000.
- Accession
- 0000950123-16-017459
- Filer
- CIK 1388325
- Filed
- 2016-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2016
A holdings report, 17 entries on the cover page, a total value of $912,484,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $912,485,000 with VALUE read as thousands by filing date, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VTI | 922908769 | COM | 2,837,100 | $297,385,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 4,910,487 | $207,566,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 3,549,320 | $159,648,000 | thousands by filing date | |
| Vanguard FTSE Europe ETF | 922042874 | SHS | 2,101,000 | $101,941,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 3,154,046 | $45,734,000 | thousands by filing date | |
| COLUCID PHARMACEUTICALS INC | 19716T101 | COM | 3,056,563 | $18,951,000 | thousands by filing date | |
| TOBIRA THERAPEUTICS INC COM | 88883P101 | COM | 2,281,405 | $18,662,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 673,063 | $17,762,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 263,191 | $12,107,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 874,985 | $7,840,000 | thousands by filing date | |
| INVUITY INC | 46187J205 | COM NEW | 936,193 | $6,759,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617126 | RIGHT 03/01/2019 | 4,622,032 | $5,778,000 | thousands by filing date | principal |
| HTG MOLECULAR DIAGNOSTICS IN | 40434H104 | COM | 1,280,185 | $3,674,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760C107 | COM | 236,826 | $3,439,000 | thousands by filing date | |
| TOKAI PHARMACEUTICALS INC COM | 88907J107 | Stock | 470,946 | $2,642,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 101,106 | $1,705,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 127,563 | $892,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-16-017459 | this filing | 2016-05-16 | acceptance time not in the bulk data set |